Read in: Español

Left Bundle Branch Area Pacing (LBBAP): Technique, Evidence & Outcomes

Last updated: May 22, 2026 · Reading time: ~11 min

AI-Generated Content. This article is produced and curated by an AI editorial pipeline at ABC Farma using publicly available device documentation and published literature. It is intended for educational purposes only, may contain inaccuracies, and is not a substitute for current device labeling, manufacturer training, or clinical judgment. Always verify against current guidelines and peer-reviewed evidence before clinical application.

Left Bundle Branch Area Pacing (LBBAP) has emerged as the most practical form of conduction system pacing — combining the physiological advantages of His bundle pacing with the implant predictability and electrical stability of a deep septal lead. In the space of roughly five years, it has moved from a single-center curiosity into mainstream electrophysiology practice, and into a growing body of randomized data.

This article reviews the anatomy and rationale, the implant technique, how to confirm capture electrocardiographically, the current evidence vs. conventional RV pacing and biventricular CRT, and how to think about patient selection.

Conduction system pacing: the landscape at a glance

Strategy Capture target QRS morphology Typical threshold Implant success
RV apical pacingRV myocardium (apex)Wide LBBB pattern0.5–1.0 V @ 0.4 ms>99%
RV septal pacingRV septumModerately wide LBBB pattern0.5–1.0 V @ 0.4 ms>99%
His bundle pacing (HBP)Bundle of HisNarrow, often near-native1.0–2.5 V (variable, can rise)~70–85%
LBBAPLBB / deep septum near LBBRBBB pattern in V1; short V6 R-peak time0.5–1.0 V @ 0.4 ms~85–95%
Biventricular CRTRV + LV epicardial via coronary sinusFusion-paced, variable1.5–3.0 V @ 0.4 ms (LV lead)~90–95%

Ranges reflect typical published series; individual outcomes vary with operator experience, anatomy, and lead system.

Why conduction system pacing matters

Decades of follow-up after pacemaker implantation have made one signal clear: a high burden of right ventricular apical pacing produces electrical and mechanical dyssynchrony that, in vulnerable patients, leads to pacing-induced cardiomyopathy (PICM). DAVID, MOST, and BLOCK-HF demonstrated this trade-off from different angles — minimizing RV pacing helps, but in patients who genuinely need ventricular pacing, RV-only strategies remain physiologically unfavorable.

Conduction system pacing aims to bypass the problem by reactivating the heart through its own His-Purkinje network. If the lead can capture the conduction system, the LV depolarizes through Purkinje fibers as nature intended — producing a narrower QRS, better LV synchrony, and, in observational and small randomized series, lower rates of heart failure hospitalization compared with chronic RV pacing.

Anatomy — what we are aiming at

The left bundle branch

The His bundle penetrates the membranous septum and divides into the right and left bundle branches. The left bundle branch fans out across the LV septal endocardium within roughly the proximal 1–2 cm below the membranous septum, before splitting into anterior and posterior fascicles. From an LBBAP perspective, this fan-shaped network of fibers occupies a relatively predictable target zone in the basal-to-mid septum, accessible from the RV side by penetrating deep into the septum.

Why a deep septal trajectory works

The LBB lies just beneath the LV-side endocardium. By rotating a fixation helix through the RV septal wall toward the LV endocardium, the helix tip can be positioned within millimeters of the LBB fibers. Capture of either the proximal LBB itself (selective LBB capture) or the LBB plus surrounding septal myocardium (non-selective LBB capture) is the goal.

Capture definitions and confirmation

The four capture states you need to recognize. Selective LBB capture (sLBB) — pacing captures only the LBB, isoelectric segment between stimulus and QRS. Non-selective LBB capture (nsLBB) — LBB plus adjacent septal myocardium captured simultaneously; QRS onset immediately follows stimulus. LV septal capture (LVSC) — deep septal capture without true LBB engagement; less physiological but still narrower than RV pacing. RV septal capture — helix has not advanced deep enough; same dyssynchrony profile as conventional RV pacing.

Electrocardiographic markers

Implant technique — a clinician’s overview

The general workflow shared across modern LBBAP systems:

  1. Sheath delivery. A pre-shaped delivery sheath (manufacturer-specific) is advanced via the axillary or subclavian approach to the RV side of the basal-to-mid interventricular septum, ideally targeting a region 1.5–2 cm below the tricuspid annulus on the RV septal surface.
  2. Mapping. Pacing from the sheath tip or initial lead position is used to confirm a "W" pattern in V1 with notching at the nadir, consistent with capture of mid-septal myocardium — the canonical signature of a good starting site for deep septal advancement.
  3. Helix advancement. The lead is rotated several turns to drive the helix through the septum toward the LV side. Operators watch fluoroscopic depth, impedance, and paced QRS evolution: the V1 morphology should progress from "W" toward terminal R, and the V6 RWPT should shorten as the lead approaches the LBB.
  4. Confirmation. Capture confirmation maneuvers (decreasing output, paced 12-lead) are performed at the suspected LBB capture site. Acceptable capture is selective LBB, non-selective LBB, or, at minimum, LV septal capture with a clearly narrower QRS than baseline.
  5. Septal perforation surveillance. Watch for sudden impedance drop, loss of pacing capture, or current of injury changes — these can indicate that the helix has reached or crossed the LV endocardium. Repositioning is preferred to leaving a perforated lead in place.

Evidence base

LBBAP vs. RV pacing

Multiple observational and randomized series — including LBBP-RESYNC, the MELOS registry, and the comparative dataset from the International LBBAP Collaborative — have shown that LBBAP produces a narrower QRS, better LV ejection fraction preservation, and lower rates of heart failure hospitalization than chronic RV pacing in patients with high pacing burden. In patients with reduced baseline LV function, the gap widens.

LBBAP vs. biventricular CRT

In the LBBP-RESYNC randomized trial and a growing number of observational comparisons, LBBAP has produced LV reverse remodeling at least equivalent to biventricular CRT in patients with LBBB and reduced ejection fraction, with shorter procedure times and lower fluoroscopy in many centers. Hybrid approaches that combine LBBAP with a coronary sinus LV lead (HOT-CRT, LOT-CRT) are an active area of research for non-responders to either single strategy.

Lead performance over time

Reported capture thresholds at implant are typically 0.5–1.0 V at 0.4 ms with R-wave amplitudes >5 mV. Multi-year follow-up data from registries such as MELOS suggest that thresholds and sensing remain stable in the majority of patients, though long-term lead performance and extractability beyond 5–10 years remain under study.

Patient selection

LBBAP is most clearly favored over RV pacing in three scenarios:

Conversely, LBBAP offers less marginal benefit (and the same procedural risks) in patients who will be paced rarely — for example, sinus node dysfunction with intact AV conduction and a low projected ventricular pacing percentage. In such patients, conventional RV pacing with strong RV pacing avoidance algorithms remains reasonable.

Procedural risks and unresolved questions

How LBBAP relates to leadless pacing

Both LBBAP and leadless pacing aim to address the long-term limitations of conventional transvenous RV pacing — but they answer different problems. LBBAP addresses the physiology of pacing (avoiding RV-only dyssynchrony) and requires a transvenous lead. Leadless pacemakers (Aveir VR, Micra) address the hardware of pacing (avoiding leads and pockets) but still pace the RV myocardium. Combining both — truly leadless conduction system pacing — is an active area of research but not yet commercially available.

Frequently asked questions

Is LBBAP the same as His bundle pacing?

No. His bundle pacing captures the bundle of His just distal to the AV node, whereas LBBAP captures the left bundle branch or surrounding septum, several millimeters more distal. LBBAP has higher implant success and lower, more stable thresholds than HBP, with similar physiological benefit in most patients.

How do operators know they have actually captured the left bundle and not just the septum?

The most specific confirmation is a visible transition between capture states at decreasing output — for example, nsLBB capture transitioning to sLBB capture (an isoelectric segment appears) or to LV septal capture (V6 RWPT lengthens). Short and stable V6 R-peak times, an RBBB pattern in V1, and a Purkinje potential preceding the local electrogram together support LBB capture.

Can LBBAP be combined with conventional CRT?

Yes — "HOT-CRT" (His-optimized CRT) and "LOT-CRT" (LBBAP-optimized CRT) refer to strategies that combine a conduction system pacing lead with a coronary sinus LV lead. These hybrid approaches are being evaluated in patients who do not respond fully to either strategy alone.

What pacing thresholds and R waves are expected with LBBAP?

Typical implant capture thresholds are 0.5–1.0 V at 0.4 ms with sensed R waves above 5 mV. Threshold drift over the first weeks to months is generally small. Sustained large rises in threshold should prompt evaluation for lead position change, micro-dislodgement, or fibrosis.

What happens if the lead perforates into the LV cavity at implant?

Septal perforation is recognized intraprocedurally by an abrupt drop in impedance, sudden change in QRS morphology, loss of capture, or current-of-injury change. The standard response is to withdraw the helix and reposition the lead at a slightly different septal site. Leaving a perforated lead in place is avoided because of the risk of thrombus formation and systemic embolism.

Is LBBAP only for heart failure patients?

No. LBBAP is being used across the full spectrum of pacing indications, including standard AV block in patients with preserved ejection fraction. The strongest case is in patients with reduced EF or anticipated high pacing burden, but the technique itself is not restricted to heart failure.

References and further reading

Related topics on ABC Farma

Reminder. All content on ABC Farma is generated by AI for educational purposes only. It is not clinical advice, does not establish a clinician-patient relationship, and may be inaccurate or outdated. Decisions about diagnosis, devices, and treatment should be made by a qualified clinician using current device labeling and the latest peer-reviewed evidence.